# Effect of pH on niacinamide skin permeation

**Authors:** Thomas Sjöberg, Silvia Letasiova, Skaidre Jankovskaja, Nina Hrapovic, Christina Österlund, Emelie Nilsson, Johan Engblom, Peter Spégel, Sebastian Björklund

PMC · DOI: 10.1038/s41598-026-41992-4 · 2026-03-24

## TL;DR

This study shows that neutral pH increases niacinamide absorption through skin by altering lipid structures, which is important for skincare product formulation.

## Contribution

The study reveals how pH affects niacinamide permeation through reversible changes in stratum corneum lipid organization.

## Key findings

- Neutral pH (7.4) increases niacinamide permeation by about twofold compared to acidic pH (5.0).
- pH changes alter stratum corneum lipid domains, affecting membrane resistance and capacitance.
- Microbial conversion of niacinamide to nicotinic acid becomes detectable after prolonged exposure.

## Abstract

Niacinamide (NIA) is a widely used skincare ingredient with established benefits for skin barrier support, inflammation reduction, and dermal health. However, the mechanisms governing its transdermal delivery remain insufficiently understood, particularly regarding how formulation pH influences its permeation through the stratum corneum (SC). This study investigates how donor phase pH (5.0 vs. 7.4) modulates NIA skin permeation and how these effects relate to pH induced changes in SC electrical properties. Franz cell diffusion experiments were combined with electrical impedance spectroscopy (EIS) using full‑thickness human skin and 3D reconstructed epidermal tissue models. Permeation was quantified over 24 h and in pH switch experiments, while EIS characterized pH dependent changes in membrane resistance (Rmem) and effective capacitance (Ceff). Additional analyses assessed microbial conversion of NIA to nicotinic acid during prolonged exposure. Neutral donor pH (7.4) increased NIA permeation by roughly twofold compared with acidic pH (5.0) in both membrane types. Correspondingly, pH 7.4 decreased Rmem and increased Ceff, indicating pH driven changes in SC lipid organization and dielectric behavior. These effects were reversible and likely stem from alterations in SC lipid domains, including pH dependent partial deprotonation of free fatty acids that modifies the continuous lipid regions and introduce localized structural microdefects. Such changes enhance NIA and ion permeability and increase SC dielectric properties at neutral pH. Although microbial conversion of NIA to nicotinic acid was negligible within the first 24 h, it became clearly detectable upon prolonged experiments. In conclusion, donor phase pH is a critical determinant of NIA skin permeation, primarily through reversible modulation of SC lipid structure and transport pathways. These findings highlight the importance of pH control in topical formulations and underscore the need to consider microbiota‑mediated transformations when evaluating the efficacy and safety of skin care products containing NIA.

The online version contains supplementary material available at 10.1038/s41598-026-41992-4.

## Linked entities

- **Chemicals:** niacinamide (PubChem CID 936), nicotinic acid (PubChem CID 938)

## Full-text entities

- **Genes:** KRT10 (keratin 10) [NCBI Gene 3858] {aka BCIE, BIE, CK10, EHK, EHK2, EHK2A}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}
- **Diseases:** rosacea (MESH:D012393), acne (MESH:D000152), atopic dermatitis (MESH:D003876), inflammation (MESH:D007249)
- **Chemicals:** PVDF (MESH:C024865), hydrogen (MESH:D006859), hydroquinone (MESH:C031927), pyridine (MESH:C023666), silicone (MESH:D012828), hydrocortisone (MESH:D006854), Na+ (MESH:D012964), heptane (MESH:D006536), ceramide (MESH:D002518), C6H8O7 (MESH:D019343), Citrate buffer (-), potassium dihydrogen phosphate (MESH:C013216), cholesterol (MESH:D002784), proton (MESH:D011522), NaN3 (MESH:D019810), C7H16 (MESH:C028618), transcutol (MESH:C010111), propylene glycol monolaurate (MESH:C098387), lactic acid (MESH:D019344), TMCS (MESH:C039293), fatty acid (MESH:D005227), mercury (MESH:D008628), CH3OH (MESH:D000432), CBS (MESH:C044169), dimethyl isosorbide (MESH:C040079), trisodium citrate (MESH:C514290), ethanol (MESH:D000431), t-butyl alcohol (MESH:D020002), PBS (MESH:D007854), propylene glycol (MESH:D019946), polyethylene glycols (MESH:D011092), MSTFA (MESH:C086665), kynurenine (MESH:D007737), SDS (MESH:D012967), testosterone (MESH:D013739), corticosterone (MESH:D003345), NA (MESH:D009525), alcohols (MESH:D000438), sucrose (MESH:D013395), sodium citrate dihydrate (MESH:D000077559), HCl (MESH:D006851), raffinose (MESH:D011887), isopropyl myristate (MESH:C008205), arbutin (MESH:D001104), CO2 (MESH:D002245), mannitol (MESH:D008353), free fatty acid (MESH:D005230), water (MESH:D014867), inulin (MESH:D007444), glycerol (MESH:D005990), agar (MESH:D000362), Methoxyamine hydrochloride (MESH:C005214), glucose (MESH:D005947), nitrogen (MESH:D009584), urea (MESH:D014508), NaCl (MESH:D012965), lipid (MESH:D008055), C6H5NO2 (MESH:C030614), C6H6N2O (MESH:D009536), HCOOH (MESH:C030544)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823]
- **Cell lines:** -TOP-12 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TT29)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018549/full.md

---
Source: https://tomesphere.com/paper/PMC13018549